T. C. Quinn, M. J. Wawer, N. Sewankambo, D. Serwadda, C. Li et al., Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group, N Engl J Med, vol.342, pp.921-929, 2000.

M. J. Wawer, R. H. Gray, N. K. Sewankambo, D. Serwadda, X. Li et al., Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, J Infect Dis, vol.191, pp.1403-1409, 2005.

P. M. Garcia, L. A. Kalish, J. Pitt, H. Minkoff, T. C. Quinn et al., Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group, N Engl J Med, vol.341, pp.394-402, 1999.

J. R. Lingappa, J. P. Hughes, R. S. Wang, J. M. Baeten, C. Celum et al., Partners in Prevention HSVHIVTST: Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk, PLoS One, vol.5, p.12598, 2010.

M. Hisada, T. R. O'brien, P. S. Rosenberg, and J. J. Goedert, Virus load and risk of heterosexual transmission of human immunodeficiency virus and hepatitis C virus by men with hemophilia. The Multicenter Hemophilia Cohort Study, J Infect Dis, vol.181, pp.1475-1478, 2000.

V. Novitsky, T. Ndung'u, R. Wang, H. Bussmann, F. Chonco et al.,

V. Gruttola, B. D. Walker, and M. Essex, Extended high viremics: a substantial fraction of individuals maintain high plasma viral RNA levels after acute HIV-1 subtype C infection, AIDS, vol.25, pp.1515-1522, 2011.

V. Novitsky, R. Wang, H. Bussmann, S. Lockman, M. Baum et al., HIV-1 subtype C-infected individuals maintaining high viral load as potential targets for the "test-and-treat" approach to reduce HIV transmission, PLoS One, vol.5, p.10148, 2010.

M. S. Cohen, Y. Q. Chen, M. Mccauley, T. Gamble, M. C. Hosseinipour et al., Prevention of HIV-1 infection with early antiretroviral therapy, N Engl J Med, vol.365, pp.493-505, 2011.

C. E. Oldenburg, T. Barnighausen, F. Tanser, C. C. Iwuji, D. Gruttola et al., Antiretroviral therapy to prevent HIV acquisition in serodiscordant couples in a hyperendemic community in rural South Africa, Clin Infect Dis, 2016.

, Botswana in the era of successful scale-up of ART, Abstract TUPDC0103. IAS, 2016.

T. Gaolathe, K. E. Wirth, M. P. Holme, J. Makhema, S. Moyo et al., Botswana Combination Prevention Project study team: Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey, Lancet HIV, vol.3, pp.221-230, 2016.

T. Gaolathe, K. Wirth, M. P. Holme, J. Makhema, S. Moyo et al., Botswana is Close to Meeting UNAIDS 2020 Goals of 90-90-90 Coverage. Abstract 16-1447, 2016.

V. Novitsky, T. Gaolathe, M. Mmalane, S. Moyo, M. P. Holme et al., Young HIV+ Adults in Botswana Less Likely to Seek Treatment or be Virally Suppressed. Abstract 16-1588, 2016.

T. Rehle, L. Johnson, T. Hallett, M. Mahy, A. Kim et al., A Comparison of South African National HIV Incidence Estimates: A Critical Appraisal of Different Methods, PLoS One, vol.10, p.133255, 2015.

Y. T. Duong, R. Kassanjee, A. Welte, M. Morgan, A. De et al.,

. Subtypes, PLoS One, vol.10, p.114947, 2015.

B. Rosner, R. J. Glynn, and M. L. Lee, Incorporation of clustering effects for the Wilcoxon rank sum test: a large-sample approach, Biometrics, vol.59, pp.1089-1098, 2003.

S. Datta and G. A. Satten, A Signed-Rank test for Clustered Data, Biometrics, vol.64, pp.501-507, 2008.

J. P. Shaffer, Multiple hypothesis testing, Annual Rev Psychol, vol.46, pp.561-576, 1995.

. R-core-team, R: A language and environment for statistical computing, R Foundation for Statistical Computing, 2016.

E. J. Tchetgen and K. Phiri, Evaluation of medication-mediated effects in pharmacoepidemiology, Epidemiology, 2016.

T. C. Quinn, R. Brookmeyer, R. Kline, M. Shepherd, R. Paranjape et al., Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence, AIDS, vol.14, pp.2751-2757, 2000.

V. Novitsky, H. Bussmann, L. Okui, A. Logan, S. Moyo et al., Estimated age and gender profile of individuals missed by a home-based HIV testing and 24 counselling campaign in a Botswana community. PMCID: PMC4450241, J Int AIDS Soc, vol.18, 2015.

H. Huerga, G. Van-cutsem, B. Farhat, J. Reid, M. Bouhenia et al., Who needs to be targeted for HIV testing and treatment in KwaZulu-Natal? Results from a population-based survey, J Acquir Immune Defic Syndr, 2016.

P. Cherutich, A. A. Kim, T. A. Kellogg, K. Sherr, A. Waruru et al., Detectable HIV Viral Load in Kenya: Data from a Population-Based Survey, PLoS One, vol.11, p.154318, 2016.

V. Novitsky and M. Essex, Using HIV viral load to guide treatment-for-prevention interventions, Curr Opin HIV AIDS, vol.7, pp.117-124, 2012.

T. A. Crowell and H. Hatano, Clinical outcomes and antiretroviral therapy in 'elite' controllers: a review of the literature, J Virus Erad, vol.1, pp.72-77, 2015.

B. D. Walker, Elite control of HIV Infection: implications for vaccines and treatment, Top HIV Med, vol.15, pp.134-136, 2007.

L. M. Eyzaguirre, M. Charurat, R. R. Redfield, W. A. Blattner, J. K. Carr et al., Elevated hypermutation levels in HIV-1 natural viral suppressors, Virology, vol.443, pp.306-312, 2013.

T. Miura, M. A. Brockman, C. J. Brumme, Z. L. Brumme, J. M. Carlson et al., Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes, J Virol, vol.82, pp.8422-8430, 2008.

T. Miura, Z. L. Brumme, M. A. Brockman, P. Rosato, J. Sela et al., Impaired replication capacity of acute/early viruses in persons who become HIV controllers, J Virol, vol.84, pp.7581-7591, 2010.

J. W. Mellors, L. A. Kingsley, C. Rinaldo, J. A. Todd, B. S. Hoo et al., Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion, Ann Intern Med, vol.122, pp.573-579, 1995.

H. Farzadegan, D. R. Hoover, J. Astemborski, C. M. Lyles, J. B. Margolick et al., Sex differences in HIV-1 viral load and progression to AIDS, Lancet, vol.352, pp.1510-1514, 1998.

D. A. Katzenstein, S. M. Hammer, M. D. Hughes, H. Gundacker, J. B. Jackson et al., The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team, N Engl J Med, vol.335, pp.1091-1098, 1996.

T. R. Sterling, D. Vlahov, J. Astemborski, D. R. Hoover, J. B. Margolick et al., Initial plasma HIV-1 RNA levels and progression to AIDS in women and men, N Engl J Med, vol.344, pp.720-725, 2001.
DOI : 10.1056/nejm200103083441003

T. R. Sterling, C. M. Lyles, D. Vlahov, J. Astemborski, J. B. Margolick et al., Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconverters, J Infect Dis, vol.180, pp.666-672, 1999.
DOI : 10.1086/314967
URL : https://academic.oup.com/jid/article-pdf/180/3/666/17993440/180-3-666.pdf

J. S. Evans, T. Nims, J. Cooley, W. Bradley, L. Jagodzinski et al., Serum levels of virus burden in early-stage human immunodeficiency virus type 1 disease in women, J Infect Dis, vol.175, pp.795-800, 1997.

M. Moroni, Sex differences in HIV-1 viral load and progression to AIDS. ICONA Study Group. Italian cohort of HIV-1 positive individuals, Lancet, vol.353, pp.589-590, 1999.

B. Grinsztejn, L. Smeaton, R. Barnett, K. Klingman, J. Hakim et al., Sex-associated differences in pre-antiretroviral therapy plasma HIV-1 RNA in diverse areas of the world vary by CD4(+) T-cell count, Antivir Ther, vol.16, pp.1057-1062, 2011.

L. A. Kalish, A. C. Collier, T. P. Flanigan, and P. N. Kumar, Plasma human immunodeficiency virus (HIV) type 1 RNA load in men and women with advanced HIV-1 disease, J Infect Dis, vol.182, pp.603-606, 2000.
DOI : 10.1086/315710
URL : https://academic.oup.com/jid/article-pdf/182/2/603/17999175/182-2-603.pdf

G. Fang, F. P. Siegal, B. Weiser, R. Grimson, K. Anastos et al., Measurement of human immunodeficiency virus (HIV) type 1 RNA load distinguishes progressive infection from nonprogressive HIV-1 infection in men and women, Clin Infect Dis, vol.25, pp.332-333, 1997.

C. A. Donnelly, L. M. Bartley, A. C. Ghani, L. Fevre, A. M. Kwong et al.,

A. I. Sighem, F. De-wolf, R. A. Rode, and R. M. Anderson, Gender difference in HIV-1 RNA viral loads, HIV Med, vol.6, pp.170-178, 2005.

C. Junghans, B. Ledergerber, P. Chan, R. Weber, and M. Egger, Sex differences in HIV1 viral load and progression to AIDS. Swiss HIV Cohort Study, Lancet, vol.353, pp.590-581, 1999.